BDBM464291 3-(4-(1H-pyrazol-4- yl)phenyl)-1-(3- methoxybenzyl)-8- (tetrahydro-2H-pyran- 4-carbonyl)-1,3,8- triazaspiro[4.5]decan- 2-one, TFA::US10787450, Example 173

SMILES COc1cccc(CN2C(=O)N(CC22CCN(CC2)C(=O)C2CCOCC2)c2ccc(cc2)-c2cn[nH]c2)c1

InChI Key InChIKey=IBBSFSGUMBZFHB-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 464291   

TargetRho-associated protein kinase 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM464291(3-(4-(1H-pyrazol-4- yl)phenyl)-1-(3- methoxybenzyl...)
Affinity DataIC50: <3nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent